How do you survive and dominate an Indian pharma market where 60,000 generic brands launch every single year? Dr. Vijay Charlu (President - India Business, Corona Remedies Limited) breaks down the ultimate playbook for molecule selection, market disruption, and successful brand acquisitions.

The rules of the pharmaceutical industry have fundamentally shifted. Traditional marketing is dead, and market disruption is the new norm. In this episode of Game of Pharma, we sit down with Dr. Vijay Charlu to uncover why scaling matters more than product value, how to spot portfolio gaps, and the real reason most private equity pharma acquisitions fail (Hint: It’s not the money).

If you are a pharma executive, marketer, entrepreneur, or investor looking to understand the mechanics of the Indian drug market, this masterclass is for you.

If you found this breakdown valuable, don't forget to Like, Subscribe, and hit the Notification Bell to stay ahead of the curve in the pharma ecosystem!

Connect with Dr. Vijay Charlu on LinkedIn:  / vijaycharlu  

LISTEN ON PODCAST:

Apple Podcasts: https://podcasts.apple.com/us/podcast...

Spotify: https://open.spotify.com/show/4EDgDoe...

GAME OF PHARMA NEWSLETTER:

Weekly pharma insights delivered to your inbox

Subscribe: https://game-of-pharma.beehiiv.com

Host LinkedIn -  / lokesh-sharma-7250a71a9  

Follow us on social media - 

Website : https://gameofpharma.com/

Instagram : https://www.instagram.com/gameofpharm...

LinkedIn :  / game-of-pharma-podcast